The effect of coconut oil consumption on improving the weakness of COVID-19 patients

Phase 2

Conditions: COVID- 19.
COVID-19, virus identified
U07.1

Registration Number: IRCT20200418047125N1

Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 28

Inclusion Criteria

Patients 18-80 years old
have been diagnosed COVID-19, According to the information registration system of Mashhad University of Medical Sciences
hospitalized at home

Exclusion Criteria

History of Allergy to coconut and its derivatives
Dissatisfaction with inclusion in the study
Severe illness and need for hospitalization

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Weakness. Timepoint: End of the first and second week. Method of measurement: According to the VAS criteria.

Secondary Outcome Measures

Name	Time	Method
Fever. Timepoint: At the end of the first and second week. Method of measurement: Thermometer.;Intensity and frequency of cough. Timepoint: At the end of the first and second week. Method of measurement: Visual Scale Scoring or VAS.;Myalgia. Timepoint: At the end of the first and second week. Method of measurement: Visual Scale Scoring or VAS.;Respiratory rate. Timepoint: At the end of the first and second week. Method of measurement: count respiratory rate in one minute.;Hospitalization. Timepoint: At the end of the first and second week. Method of measurement: The ratio of the number of cases leading to hospitalization to the total number of patients in each group.